The innovative formula of pelviprost® somatic modulates neuroinflammation and neurochemical imbalances.
A new pathway opened up by scientific research now offers a comprehensive treatment for the management of lower urinary tract symptoms (LUTS) and mood swings, two conditions that are self-perpetuating as a result of peripheral and central neuroinflammatory processes, with significant repercussions on quality of life.
The commitment of Epitech Group is therefore directed at modulating nervous reactivity and at regulating the neurochemical imbalances in the glutamatergic and GABAergic systems, which underlie muscle tension, pain symptoms and mood disorders.
The innovative patented formula – Pelviprost® somatico – acts in a combined manner on the stabilisation of the pelvic tissues and spinal somatic pathway, thanks to its synergistic combination of ingredients with high bioavailability and proven efficacy in favouring physiological tissue reactivity.